Nijmegen, November 21
EACPT focus meeting ‘Drugs to fight cardiovascular damage’
At the start of the summer holidays, the first week after students had left the University Campus, a small but high quality meeting was organized by the European Association of Clinical Pharmacology and Therapeutics focusing on new targets to prevent cardiovascular damage. During this three day meeting (3-5 July) 85 clinical scientists from all over the world (apart from almost all European countries, also people from Australia, Taiwan, the United States) visited Nijmegen to share new ideas.…
Continue reading the "EACPT Focus Meeting 2014 in Nijmegen" »
Around 600 young and senior delegates from 5 continents were in Geneva at the end of August, for the 11th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT).
See below blogs by international delegates on sessions at the 2013 EACPT Congress in Geneva.
Laura Wilkins, University of Warwick, UK
Professor Gunther Hartmann on Oligonucleotide-based Immunotherapy: On the first evening of the 11th EACPT congress in Geneva, Professor Hartmann (Head of the BONFOR research committee at the University of Bonn) introduced congress participants to the world of oligonucleotide-based immunotherapy.…
Continue reading the "Posts by delegates from the 11th EACPT Congress in Geneva" »
We are exited to pronounce that the Location for the 2019 EACPT congress is set already. We are looking Forward to be guests of the wonderful city of Stockholm.…
Continue reading the "14th congress of the EACPT 2019 in Stockholm" »
Under the auspices of the Swiss Society of Clinical Pharmacology and Toxicology, the 11th biennial Congress of the European Association for Clinical Pharmacology and Therapeutics took place in Geneva between the 28th and the 31st of August 2013 and was co-chaired by Pierre Dayer, Marie Besson and Caroline Samer.
The Geneva Congress brought together around 600 international delegates, including health professionals, clinical and life scientists, policy makers, professionals from the biotechnology and pharmaceutical communities and others interested in the spectrum from basic to clinical pharmacology and pharmacotherapy, and from drug discovery to regulatory affairs.…
Continue reading the "Geneva Congress 2013" »